Intratympanic steroid injection for sudden sensorineural hearing loss: Impact of injection interval on therapeutic efficacy

Min Young Kwak, Chan Ju Yang, Hyun Joon Shim, Chan Il Song, Jong Yang Kim, Il Woo Lee, Sung Wook Jung, Hyun Woo Lim, Joong Keun Kwon, Jun Ho Lee, June Choi, Yun Suk An, Kyu Yup Lee, Jong Woo Chung

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Objective: To compare the effect of injection time intervals of intratympanic (IT) dexamethasone (DEX) in patients with idiopathic sudden sensorineural hearing loss (ISSNHL). Methods: Seventy-five adults with ISSNHL were grouped into four groups according to the IT DEX interval. In addition to concurrent oral steroid medication for two weeks, patients received IT DEX injections every 1, 2, 3, and four days, respectively. (Group 1, Group 2, Group 3, and Group 4). We evaluated the treatment outcomes according to modified criteria from “Clinical Practice Guideline: Sudden Hearing Loss” of the American Academy of Otolaryngology-Head and Neck Surgery (AAO–HNS) to justify treatment success. Results: There were no significant differences in demographic and baseline audiometric data. The mean of pure tone audiometry (PTA) and speech discrimination score (SDSs) were significantly improved after oral steroid and IT DEX treatment in all four groups. Group 1 showed significantly higher improvement than Group 4 in PTA after treatment. There was a significantly higher complete recovery (CR) rate in Group 1 than Group 4. Conclusion: We found a statistically significant difference in the complete hearing recovery rate and audiometric results (PTA) between the group with a daily interval of injections and the group with a four-day time interval. Therefore, daily time intervals in intratympanic steroid injection may be considered as an option for better improvement of hearing in patients with ISSNHL.

Original languageEnglish
Pages (from-to)982-989
Number of pages8
JournalAuris Nasus Larynx
Volume47
Issue number6
DOIs
Publication statusPublished - 2020 Dec
Externally publishedYes

Bibliographical note

Funding Information:
This study was supported by a grant ( 2013–0455 ) from the Asan Institute for Life Sciences , Asan Medical Center, Seoul, Korea

Publisher Copyright:
© 2020

Keywords

  • Audiometry
  • Dexamethasone
  • Intratympanic
  • Sudden hearing loss

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Fingerprint

Dive into the research topics of 'Intratympanic steroid injection for sudden sensorineural hearing loss: Impact of injection interval on therapeutic efficacy'. Together they form a unique fingerprint.

Cite this